Revenue grew 4% YoY to €4.36m with improved profitability and a strong cash position. Major healthcare partnerships and technology adoption were achieved globally, supporting ambitious growth and efficiency targets for FY 2024-2025.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.